Log In
Print
BCIQ
Print
Print this Print this
 

4SC-205

  Manage Alerts
Collapse Summary General Information
Company 4SC AG
DescriptionOral inhibitor of kinesin spindle protein (KSP; Eg5; TRIP5)
Molecular Target Kinesin spindle protein (KSP) (Eg5) (TRIP5)
Mechanism of ActionKinesin spindle protein inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today